Dostinex (cabergoline)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dostinex (cabergoline), covering 2009-04-29 to 2009-04-29. Get the full timeline:
Most recent: Clinical Trial Update: Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor [Phase 3]